Asian Pacific Journal of Cancer Prevention

  • 제15권2호
  • /
  • Pages.637-642
  • /
  • 2014
  • /
  • 1513-7368(pISSN)
  • /
  • 2476-762X(eISSN)
아시아태평양암예방학회 (Asian Pacific Journal of Cancer Prevention)
권호 표지
DOI QR코드

DOI QR Code

Impact of Chronic Hepatitis B and Hepatitis C on Adverse Hepatic Fibrosis in Hepatocellular Carcinoma Related to Betel Quid Chewing

  • Jeng, Jen-Eing (Department of Laboratory Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University) ;
  • Tsai, Meng-Feng (Department of Pediatrics, Sinchu MaKay Memorial Hospital) ;
  • Tsai, Hey-Ru (Department of Internal Medicine, Madow Sin-Lau Hospital) ;
  • Chuang, Lea-Yea (Department of Biochemistry, Kaohsiung Medical University) ;
  • Lin, Zu-Yau (Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University) ;
  • Hsieh, Min-Yuh (Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University) ;
  • Chen, Shinn-Chern (Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University) ;
  • Chuang, Wan-Lung (Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University) ;
  • Wang, Liang-Yen (Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University) ;
  • Yu, Ming-Lung (Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University) ;
  • Dai, Chia-Yen (Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University) ;
  • Tsai, Jung-Fa (Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University)
  • 발행 : 2014.01.30
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

The pathogenesis of hepatocellular carcinoma (HCC) related to habitual betel quid (BQ) chewing is unclear. Risk of HCCis increased with adverse hepatic fibrosis. This study aimed to assess the impact of chronic viral hepatitis on adverse hepatic fibrosis in HCC related to BQ chewing. This hospital-based case-control study enrolled 200 pairs of age- and gender-matched patients with HCC and unrelated healthy controls. Serologic hepatitis B surface antigen (HBsAg), antibodies to hepatitis C virus (anti-HCV), ${\alpha}$-fetoprotein (AFP), and surrogate markers for significant hepatic fibrosis were measured. Information on substance-use habits was obtained with a questionnaire. By analysis of surrogate markers for hepatic fibrosis, the prevalence of significant hepatic fibrosis in patients chewing BQ was between 45.8% and 91.7%, whereas that for patients without BQ chewing was between 18.4% and 57.9%. The difference was significant (P <0.05 for each surrogate marker). Multivariate analysis indicated that cirrhosis with Child-Pugh C (odds ratio (OR) = 3.28; 95% confidence interval (CI), 1.29-8.37), thrombocytopenia (OR = 3.92, 95% CI, 1.77-8.68), AFP >400 mg/L (OR = 2.21, 95% CI, 1.05-4.66) and male gender (OR = 4.06, 95% CI, 1.29-12.77) were independent factors associated with habitual BQ chewing. In conclusion, adverse hepatic fibrosis and severe liver damage play important roles in the pathogenesis of BQ-related HCC, which could be aggravated by chronic hepatitis B and hepatitis C. BQ-cessation programs and prevention of chronic HBV/HCV infection are needed to prevent HCC related to BQ chewing.

키워드

참고문헌

  1. Angadi PV, Rao SS (2011). Areca nut in pathogenesis of oral submucous fibrosis:Revisited. Oral Maxillofac Surg, 15, 1-9. https://doi.org/10.1007/s10006-010-0219-8
  2. Bhide SV, Shivapurkar NM, Gothoskar SV, Ranadive KJ (1979). Carcinogenicity of betel nut ingredients: Feeding mice with aqueous extract and the polyphenol fraction of betel nut. Br J Cancer, 40, 922-6. https://doi.org/10.1038/bjc.1979.286
  3. Bouchard MJ, Navas-Martin S (2011). Hepatitis B and C virus hepatocarcinogenesis: Lessons learned and future challenges. Cancer Lett, 305, 123-43. https://doi.org/10.1016/j.canlet.2010.11.014
  4. Bruce MG, Bruden D, McMahon BJ, et al (2008). Clinical significance of elevated alpha-fetoprotein in Alaskan native patients with chronic hepatitis C. J Viral Hepatitis, 15, 179-87.
  5. Chang LY, Wan HC, Lai YL, et al (2009). Areca nut extracts increased expression of inflammatory cytokines, tumor necrosis factor-alpha, interleukin-1beta, interleukin-6 and interleukin-8, in peripheral blood mononuclear cells. J Periodontal Res, 44, 175-83. https://doi.org/10.1111/j.1600-0765.2008.01104.x
  6. Chen CH, Yang PM, Huang GT, et al (2007). Estimation of seroprevalence of hepatitis B virus and hepatitis C virus in Taiwan from a large-scale survey of free hepatitis screening participants. J Formosa Med Assoc, 106, 148-55. https://doi.org/10.1016/S0929-6646(09)60231-X
  7. El-Serag HB (2012). Epidemiology of viral hepatitis and hepatocellular carcinoma. Gastroenterology, 142, 1264-73. https://doi.org/10.1053/j.gastro.2011.12.061
  8. Greene FL, Page DL, Fleming ID, et al (2002). American Joint Committee on Cancer Staging Manual. 6th edn. Spring., Philadelphia.
  9. Gumusay O, Ozenirler S, Atak A, et al (2013). Diagnostic potential of serum direct markers and non-invasive fibrosis models in patients with chronic hepatitis B. Hepatol Res, 43, 228-37. https://doi.org/10.1111/j.1872-034X.2012.01057.x
  10. Gupta PC, Warnakulasuriya S (2002). Global epidemiology of areca nut usage. Addict Biol 7, 77-83. https://doi.org/10.1080/13556210020091437
  11. Hamed MA, Ali SA (2013). Non-viral factors contributing to hepatocellular carcinoma. World J Hepatol, 5, 311-22.
  12. Hsiao TJ, Liao HW, Hsieh PS, Wong RH (2007). Risk of betel quid chewing on the development of liver cirrhosis: a community-based case-control study. Ann Epidemiol, 17, 479-85. https://doi.org/10.1016/j.annepidem.2006.12.007
  13. International Agency for Research on Cancer (IARC) (2004). Betel-quid and areca-nut chewing and some areca-nut derived nitrosamines. IARC Monogr Eval Carcinog Risks Hum, 85, 1-334.
  14. Jemal A, Bray D, Center MM, et al (2011). Global cancer statistics. CA Cancer J Clin, 61, 69-90. https://doi.org/10.3322/caac.20107
  15. Jeng JE , Tsai HR, Chuang LY, et al (2009). Independent and additive interactive effects among tumor necrosis factor-$\alpha$ polymorphisms, substance use habits, and chronic hepatitis B and hepatitis C virus infection on risk for hepatocellular carcinoma. Medicine, 88, 349-57. https://doi.org/10.1097/MD.0b013e3181c10477
  16. Jeng JE, Tsai JF, Chuang LY, et al (2007). Tumor necrosis factor-$\alpha$ 308.2 polymorphism is associated with advanced hepatic fibrosis and higher risk for hepatocellular carcinoma. Neoplasia, 9, 987-92. https://doi.org/10.1593/neo.07781
  17. Kee KM, Lu SN (2011). Hospital- and community-based screenings for hepatocellular carcinoma in Taiwan. Oncology, 81 Suppl , 36-40. https://doi.org/10.1159/000333257
  18. Ko YC, Chiang TA, Chang SJ, Hsieh SF (1992). Prevalence of betel quid chewing habit in Taiwan and related sociodemographic factors. J Oral Pathol Med, 21, 261-4. https://doi.org/10.1111/j.1600-0714.1992.tb01007.x
  19. Kong X, Horiguchi N, Mori M, Gao B (2012). Cytokines and STATs in liver fibrosis. Front Physiol, 3, 69.
  20. Lackner C , Struber G, Liegl B, et al (2005). Comparison and validation of simple noninvasive tests for prediction of fibrosis in chronic hepatitis C. Hepatology, 41, 1376-82. https://doi.org/10.1002/hep.20717
  21. Lee CH, Ko AM, Warnakulasuriya S, et al (2011). Intercountry prevalences and practices of betel-quid use in south, southeast and eastern Asia regions and associated oral preneoplastic disorders: an international collaborative study by Asian betel-quid consortium of south and east Asia. Int J Cancer, 129, 741-51.
  22. Lin CF, Shiau TJ, Ko YC, Chen PH, Wang JD (2008). Prevalence and det erminants of biochemical dysfunction of the liver in Atayala aboriginal community of Taiwan: is betel nut chewing a risk factor? BMC Gastroenterol, 8, 13. https://doi.org/10.1186/1471-230X-8-13
  23. Lee CH, Ko AM, Warnakulasuriya S, et al (2011). Intercountry prevalences and factors of betel-quid use in south, southeast and eastern Asia regions and associated oral preneoplastic disorders: an international collaborative study by Asian betel-quid consortium of south and east Asia. Int J Cancer, 129, 1741-51. https://doi.org/10.1002/ijc.25809
  24. Lin CW, Hsieh YS, Hsin CH, et al (2012). Effects of NFKB1 and NFKBIA gene polymorphisms on susceptibility to environmental factors and the clinicopathologic development of oral cancer. PLoS One, 7, e35078. https://doi.org/10.1371/journal.pone.0035078
  25. Lu HH, Kao SY, Liu TY, et al (2010). Areca nut extract induced oxidative stress and upregulated hypoxia inducing factor leading to autophagy in oral cancer cells. Autophagy, 6, 725-37. https://doi.org/10.4161/auto.6.6.12423
  26. Lu SN, Wang JH, Liu SL, et al (2006). Thrombocytopenia as a surrogate for cirrhosis and a marker for the identification of patients at high-risk for hepatocellular carcinoma. Cancer, 107, 2212-22. https://doi.org/10.1002/cncr.22242
  27. Luedde T, Schwabe RF (2011). NF-$\kappa{B}$ in the liver-linking injury, fibrosis and hepatocellular carcinoma. Nat Rev Gastroenterol Hepatol, 8, 108-18. https://doi.org/10.1038/nrgastro.2010.213
  28. Matsuzaki K, Murata M, Yoshida K, et al (2007). Chronic inflammation associated with hepatitis C virus infection perturbs hepatic transforming growth factor beta signaling, promoting cirrhosis and hepatocellular carcinoma. Hepatology, 46, 48-57. https://doi.org/10.1002/hep.21672
  29. Murata M, Matsuzaki K, Yoshida K, et al (2009). Hepatitis B virus X protein shifts human hepatic transforming growth factor (TGF)-beta signaling from tumor suppression to oncogenesis in early chronic hepatitis B. Hepatology, 49, 1203-17. https://doi.org/10.1002/hep.22765
  30. Ni WF, Tsai CH, Yang SF, Chang YC (2007). Elevated expression of NF-kappaB in oral submucous fibrosis - evidence for NF-kappaB induction by safrole in human buccal mucosal fibroblasts. Oral Oncol, 43, 557-62. https://doi.org/10.1016/j.oraloncology.2006.06.007
  31. Nishikawa A, Prokopczyk B, Rivenson A, Zang E, Hoffmann D (1992). A study of betel quid Carcinogenesis. VIII. Carcinogenicity of 3- (methylnitrosamino) propionaldehyde in F344 rats. Carcinogenesis, 13, 369-72. https://doi.org/10.1093/carcin/13.3.369
  32. Rodriguez-Diaz JL, Rosas-Camargo V, Vega-Vegaz O, et al (2007). Clinical and pathological factors associated with the development of hepatocellular carcinoma in patients with hepatitis virus-related cirrhosis: A long-term follow-up study. Clin Oncol, 9, 197-203.
  33. Sarma AB, Chakrabarti J, Chakrabarti A, et al (1992). Evaluation of pan masala for toxic effects on liver and other organs. Food Chem Toxicol, 30, 161-3. https://doi.org/10.1016/0278-6915(92)90152-B
  34. Secretan B, Straif K, Baan R, et al (2009). A review of human carcinogens-Part E: tobacco, areca nut, alcohol, coal smoke, and salted fish. Lancet Oncol, 10, 1033-4. https://doi.org/10.1016/S1470-2045(09)70326-2
  35. Tsai JF, Chang WY, Jeng JE, et al (1993). Hepatitis C virus infection as a risk factor for nonalcoholic liver cirrhosis in Taiwan. J Med Virol, 41, 296-300. https://doi.org/10.1002/jmv.1890410407
  36. Tsai JF, Chuang LY, Jeng JE, et al (2001). Betel quid chewing as a risk factor for hepatocellular carcinoma: a case-control study. Br J Cancer, 84, 709-13. https://doi.org/10.1054/bjoc.1999.1597
  37. Tsai JF, Jeng JE, Chuang LY, et al (2003). Habitual betel quid chewing as a risk factor for cirrhosis: a case-control study. Medicine, 82, 365-72. https://doi.org/10.1097/01.md.0000090401.56130.59
  38. Tsai JF, Jeng JE, Chuang LY, et al (2004). Habitual betel quid chewing and risk for hepatocellular carcinoma complicating cirrhosis. Medicine, 83, 176-87. https://doi.org/10.1097/01.md.0000126971.80227.a4
  39. Yan LB, Zhu X, Bai L, et al (2013). Impact of mild to moderate elevations of alanine aminotransferase on liver stiffness measurement in chronic hepatitis B patients during antiviral therapy. Hepatol Res, 43, 185-91. https://doi.org/10.1111/j.1872-034X.2012.01068.x
  40. Zhang SS, Li WH, Gao YJ, et al (2012). Betel-quid and oral submoucous fibrosis study in Hunan province, China. J Oral Pathol Med, 41, 748-54. https://doi.org/10.1111/j.1600-0714.2012.01166.x

피인용 문헌

  1. Clinical Significance of Joint Detection of Serum VEGF, SIL-2R and HGF in Patients with Primary Hepatocellular Carcinoma before and after Percutaneous Microwave Coagulation Therapy vol.15, pp.11, 2014, https://doi.org/10.7314/APJCP.2014.15.11.4545
  2. Glutathione S-transferase M1 Null Genotype and Hepatocellular Carcinoma Susceptibility in China and India: Evidence from an Updated Meta-analysis vol.15, pp.12, 2014, https://doi.org/10.7314/APJCP.2014.15.12.4851
  3. Hepatitis C Virus Prevalence and Genotyping among Hepatocellular Carcinoma Patients in Baghdad vol.15, pp.18, 2014, https://doi.org/10.7314/APJCP.2014.15.18.7725
  4. Independent and Additive Interaction Between Tumor Necrosis Factor β +252 Polymorphisms and Chronic Hepatitis B and C Virus Infection on Risk and Prognosis of Hepatocellular Carcinoma: a Case-Control Study vol.15, pp.23, 2014, https://doi.org/10.7314/APJCP.2014.15.23.10209
  5. Analysis on Postoperative Efficacy of Radical Hepatectomy for Patients with Non-HBV/HCV Hepatocellular Carcinoma vol.16, pp.8, 2015, https://doi.org/10.7314/APJCP.2015.16.8.3479
  6. Hepatitis C Virus (HCV) genotypes distribution among hepatocellular carcinoma patients in Southern Italy: a three year retrospective study vol.12, pp.1, 2017, https://doi.org/10.1186/s13027-017-0162-5
  7. Adverse Health Effects of Betel Quid and the Risk of Oral and Pharyngeal Cancers vol.2017, pp.2314-6141, 2017, https://doi.org/10.1155/2017/3904098